1195251-01-4 Usage
Uses
Used in Pharmaceutical Industry:
4-Chloro-3-fluoro-2-Methylpyridine is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and biologically active substances. Its unique structure allows for the creation of diverse medicinal compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Chloro-3-fluoro-2-Methylpyridine is utilized as a precursor in the production of agrochemicals, helping to develop new compounds that can enhance crop protection and improve agricultural yields.
Used in Organic Compounds Synthesis:
4-Chloro-3-fluoro-2-Methylpyridine is used as a building block in the synthesis of a wide range of organic compounds, showcasing its versatility and importance in the chemical industry. Its structural attributes make it a valuable component in the creation of various organic molecules with different applications.
Used as a Biosynthetic Precursor:
4-Chloro-3-fluoro-2-Methylpyridine also holds potential as a biosynthetic precursor, playing a crucial role in the development of new drugs and other biologically active substances. Its presence in the synthesis process can lead to the discovery of innovative treatments and advancements in the field of medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 1195251-01-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,5,2,5 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1195251-01:
(9*1)+(8*1)+(7*9)+(6*5)+(5*2)+(4*5)+(3*1)+(2*0)+(1*1)=144
144 % 10 = 4
So 1195251-01-4 is a valid CAS Registry Number.
1195251-01-4Relevant academic research and scientific papers
FUSED PYRIDINES AS KINASE INHIBITORS
-
Paragraph 0183, (2018/06/04)
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
AZETIDINES AND CYCLOBUTANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS
-
Page/Page column 73, (2010/01/29)
The invention relates to compounds of formula (I) wherein R, R0, R1, m, n and X1 to X4 have the meaning as cited in the description and the claims. Said compounds are useful as Histamine H3 receptor antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.
